title: A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
authors.forename: Georges M
authors.initials: GM
authors.lastname: Gharabawi
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Bossie
authors.forename: Gahan J
authors.initials: GJ
authors.lastname: Pandina
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Kujawa
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Greenspan
authors.forename: Young
authors.initials: Y
authors.lastname: Zhu
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D010919:Placebos; D000069348:Quetiapine Fumarate; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D018967:Risperidone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010919:Placebos; D000069348:Quetiapine Fumarate; D018967:Risperidone